Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer
Does Blocking Proinflammatory Cytokines Diminish Cancer-Related Fatigue?
Sponsor: American Cancer Society, Inc.
Terminated
Recruitment stopped due to slow accrual and lack of evidence of need for further continuation of protocol in inpatient setting.
Other terminated trials from American Cancer Society, Inc.
- Colorectal Cancer · Jan 2025
- Smoking Cessation · Phase NA · Mar 2020
- Adherence, Medication · Phase PHASE2 · Mar 2020
- Non-small Cell Lung Cancer · Phase PHASE2 · Sep 2019
- Recurrent Plasma Cell Myeloma · Phase PHASE2 · Nov 2018
More terminations from American Cancer Society, Inc.
Other Breast Cancer trials with similar outcome
This PHASE2 trial investigates Breast Cancer and Fatigue and is currently terminated or withdrawn. American Cancer Society, Inc. leads this study, which shows 11 recorded versions since 2005 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 6 earlier versions
-
Aug 2020 — Nov 2020 [monthly]
Terminated PHASE2
-
Jun 2018 — Aug 2020 [monthly]
Terminated PHASE2
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE2
-
Aug 2017 — May 2018 [monthly]
Terminated PHASE2
-
Feb 2017 — Aug 2017 [monthly]
Terminated PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2
First recorded
Feb 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American Cancer Society, Inc.
- Jonsson Comprehensive Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .